NeoGenomics Financial Ratios
NASDAQ: NEOHealth CarePrecision InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
NeoGenomics ratio analysis
NeoGenomics earned a net margin of -14.9% in FY 2025, down from -11.9% a year earlier. Gross margin was 43.2% compared with a median of 42.3% over the prior 9 years. Return on equity reached -12.9%, meaning NeoGenomics generated -0.13 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.41 versus 0.60 the year before, and the current ratio was 4.26. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
NeoGenomics financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | — | — | 1,346.00 | 366.38 | 179.00 | — | — |
| Price / sales | 2.07 | 3.26 | 3.43 | 2.25 | 8.45 | 13.15 | 7.20 | 3.88 | 2.93 | 2.87 |
| Price / book | 1.80 | 2.38 | 2.16 | 1.15 | 3.69 | 8.42 | 5.80 | 3.35 | 4.09 | 4.09 |
| Gross margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | 46.0% | 42.4% | 42.3% |
| Operating margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | 3.6% | 1.2% | 0.9% |
| Net margin | -14.9% | -11.9% | -14.9% | -28.3% | -1.7% | 0.9% | 2.0% | 1.0% | -0.2% | -2.6% |
| Free cash flow margin | -3.0% | -5.2% | -5.2% | -19.0% | -18.8% | -6.2% | 0.8% | 11.0% | 1.8% | 6.0% |
| Return on equity (ROE) | -12.9% | -8.7% | -9.3% | -14.5% | -0.8% | 0.6% | 1.6% | 0.8% | -0.2% | -3.8% |
| Return on assets (ROA) | -7.9% | -4.8% | -5.2% | -8.3% | -0.4% | 0.4% | 1.1% | 0.5% | -0.1% | -1.8% |
| Debt / equity | 0.41 | 0.60 | 0.57 | 0.54 | 0.48 | 0.24 | 0.20 | 0.31 | 0.55 | 0.59 |
| Current ratio | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 | 6.13 | 4.55 | 1.70 | 2.35 | 2.07 |
| Revenue growth | 10.1% | 11.6% | 16.1% | 5.2% | 9.0% | 8.7% | 47.7% | 15.2% | 3.6% | 4,536.2% |
| EPS growth | — | — | — | — | -275.0% | -50.0% | 14.3% | — | — | — |